AI in Medicine News ・ 💊 Drug discovery and clinical trials

Can AI redesign mRNA to last weeks, not days?

Drug Discovery News 🔗 Share link 11/02 00:51 UTC 🔗 Share link GTH: H1 loss narrowed as a share raise funded a pivot toward BioTech and AI — TradingView 🔗 Share link 11/02 11:40 UTC 🔗 Share link Thailand eyes status as AI medical hub — Bangkok Post · 11/01 22:25 UTC

ScionxBio licenses its xRNA TERA platform to Sanofi. The platform targets chronic protein-deficiency diseases with AI-engineered mRNA that lasts weeks, not days.

Read the original (Drug Discovery News 🔗 Share link 11/02 00:51 UTC 🔗 Share link GTH: H1 loss narrowed as a share raise funded a pivot toward BioTech and AI — TradingView 🔗 Share link 11/02 11:40 UTC 🔗 Share link Thailand eyes status as AI medical hub — Bangkok Post)

See it in the digest → ・ See this issue →